reported, the pain is usually severe and often long-lasting.

Netherlands reports show serious Cervarix adverse events 4X more frequent than age-relevant deaths from cervical cancer.

Cervarix is UK’s most reactive vaccine.

Some of the victims

Sixteen days after her first dose of Gardasil, 15 yr old Annabelle Morin of Quebec couldn’t remember, speak, or understand speech or writing; she was weak and had trouble standing. Since no doctor admitted the injection was the cause, she accepted a second dose. Fifteen days later, she died in silence while taking a bath.

Cervarix is the UK’s taxpayer funded HPV vaccine. Nine months after her Cervarix vaccination, 13 yr old AshleighCave was still in hospital unable to stand unaided and without bladder control.

Camille Gagnon’s certainty that she wouldn’t accept Gardasil was no match for coercion by two nurses. The healthy Quebec schoolgirl was injected at 3:45 pm, unconscious then confused on a bus trip home, and in hospital by 5:45 pm with no memory of how she’d arrived. Denying the obvious conclusion, staff recommended an allergist. Nearly 2 months and numerous consultations later, she still suffered – now from chronic headaches, loss of appetite and deteriorating vision.

Tomljenovic and Shaw; Ann Med; 22/12/2012: “while the world’s leading medical authorities state that HPV vaccines are an important cervical cancer prevention tool, clinical trials show no evidence that HPV vaccine can protect against cervical cancer.”

Dr. Diane Harper, lead researcher, HPV vaccine development:"This vaccine should not be mandated for 11-year-old girls.... It's not been tested in little girls for efficacy. At 11, these girls don't get cervical cancer—they won't know for 25 years if they will get cervical cancer. Giving it to 11-year-olds is a great big public health experiment."

Commentary by Dr Abby Lippman et al;CMAJ; 28/8/2007: “In developing a model HPV vaccination program, governments shouldstart by educating the public about the reality of cervicalcancer, HPV infection and vaccinations, to quell anxieties aboutcervical cancer and HPV and to emphasize the importance of healthypersonal practices, including use of barrier methods, good nutrition,smoking cessation and regular Pap smears and screening for sexuallytransmitted infections.”

------

Vaccination Risk Awareness Network Inc. (VRAN)is theonly independentonlinesource of Canadian vaccine information.Seemore HPV vaccine information and references at:

.

HPV Vaccine

Human papillomavirus (HPV) is very common. It’s transmission is often by sexual activity but also occurs in several other ways.HPV vaccines contain HPV ‘virus-like particles’: Gardasil contains 2 associated with cervical cancer and 2 with genital warts; Cervarix contains only the 2 associated with cervical cancer.

Gardasil has been funded for Canadian schoolgirls.It’s also been recommended for schoolboys. Cervarix has been funded to “catch-up” BC women born in 1991-93.

Is it needed?

Annually, fewer than 8/100,000 get cervical cancer. HPV infection usually disappears on its own;most females who are infected have no symptoms. Since there are at least 150 HPV strains (some US FDA scientists have saidthere are “millions, virtually a continuum”) vaccination cannot provide herd immunity.

Is it effective?

Health authorities have claimed it prevents cervical cancer but there’s no evidence of this.It may prevent some HPV infections,but efficacy trials failed to track condom use,a serious flaw since condoms alone can reduce infection by all HPV types by 70%.Some scientists and doctors think HPV doesn’t cause cancer, it just invades tissues that are already developing it.Because HPV is so common yet cervical cancer is so rare, it’s likely other factors are the main cause. Some risk factors are: tobacco and marijuana use, young age at first intercourse, promiscuity, longtime use of oral contraceptives. Frequent use of a vaginal douche may also increase risk.

Regular testing prevents cancer.

Health Canada states: “the median time from acquisition of infection to the development of cervical cancer is greater than 20 years.” This is why Pap tests have been so successful; they’ve reduced cancer incidence to less than half of what it was in 1970.

Risks of the vaccines

Increased cancer.

Pre-licensing studies showed a possible increased risk of cervical cancer in females who are, and/or have previously been, infected with vaccine-type HPV at first vaccination. Since HPV can be transmitted from mother to baby and child to child, the only way to be reasonably sure the vaccine won’t cause cervical cancer is to be tested for HPV at the time of vaccination.

Vaccinated individuals may have a false sense of security, which may cause them to be careless about lifestyle choices that increase risk.

Pressure on vaccine-type HPVs from mass vaccination programs could alter the relative predominance of HPVs so that non-vaccine-types, including those that associate with cancer, become more common than the vaccine types. The claim that vaccine-type HPVs“cause 70% of cervical cancer” may have been true long ago when the vaccine was conceived but a 2007 US survey found the “oncogenic” vaccine HPVs comprised only 4%.

Risky ingredients

Gardasil contains aluminum and polysorbate. Aluminum is neurotoxic; both are known to cause cancer in lab animals andalter immune response. Cervarix contains aluminum and oil adjuvant; the latter has been linked to autoimmune disease. All these risks are repeated with e 2nd and 3rd doses of the vaccines.

Questionable safety studies

Safety trials were conducted by Merck and GSK, makers of the vaccines. Aluminum salt was used as a ‘control’ for part of the studies. The vaccine’spotential to cause human cancers, infertility, spontaneous abortion, birth defects and illness of breastfed infants was barelyresearchedor not researched at all.The risk of injection along with all other scheduled vaccines was not determined.

Poor quality control

Merck has a history of dubious products and practices. An April/08 warning letter to Merck about several of its vaccines including Gardasil states: “The deficiencies described in this letter are indicative of your quality control unit’s inability to fulfill its responsibility to assure the identity, strength, quality, and purity of your drug product and drug substance.”

Recombinant HPV DNA contaminant was found in Gardasil in 2011. It may’ve triggeredthe autoimmune disease, malignant tumours, and inflammation of joints and central nervous system some Gardasil recipients have acquired.

Gardasil rushed to market.

Gardasil was fast-tracked to approval by the US FDA. One month later it was rubber-stamped by Health Canada. Merck lobbied doctor’s groups and the Canadian Government;the highly expensive vaccine was fast-tracked again with the premature partial funding of $300 million by the Feb, 2007 federal budget. Meanwhile, the final report on post-marketing studies required by the FDA is not due until 2018.

Adverse events

As of March, 2012, US VAERS reports of adverse events from Gardasil comprised:

46% of all its reports

64% of all deaths reported

65% of all life-threatening events

61% of all serious events

81% of all permanent disabilities

‘Serious’ adverse events have included blood clot, paralysis, seizures, stroke, cardiac arrest, vasculitis (blood vessel inflammation), Guillaine-Barré syndrome, arthritis and faintingfollowed by head injuries and fractures. While a sore arm has been the most common event